LEXX (Lexaria Bioscience) Kacepetan wutah bathi saben saham ing taun lumaku
The current EPS YoY growth rate demonstrates earnings per share dynamics, with the 0.00 value serving as the baseline metric for Lexaria Bioscience (LEXX). The DehydraTECH B2B licensing model attracts new partners due to its efficiency in the GLP-1 segment. Production is fully outsourced to contract manufacturing organizations (CMO), creating a strong operational dependency. The proprietary method accelerates substance absorption, reducing both dosage and side effects.
Rincian metrik komprehensif lan analitis lexariabioscience.com (LEXX)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Utang marang Modal Lexaria Bioscience|LEXX - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal Lexaria Bioscience Corp.|LEXX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Lexaria Bioscience Corp.|LEXX - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Lexaria Bioscience|Koefisien jangkoan perantara lexariabioscience.com
- indikator pendapatan resik lan kelipatan nilai:
LEXX - Bathi resik|Proyeksi bathi mangsa ngarep Lexaria Bioscience|LEXX - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Lexaria Bioscience Corp.|LEXX - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Lexaria Bioscience Corp.|LEXX - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Lexaria Bioscience|LEXX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan lexariabioscience.com|LEXX - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Lexaria Bioscience
Pambiji fundamental:Lexaria Bioscience
Lexaria Bioscience focuses on monetizing its innovative DehydraTECH system through strategic licensing. Earnings per share dynamics reflect the efficiency of this model, comparing current financial results with the same period last year. This indicator measures the speed of business scaling and its transition toward maturity. The narrowing amplitude of fluctuations in the 12-month earnings per share growth rate signals a stabilization of market expectations. The deceleration of this growth warns investors of the risk of capital freezing.
Pesaing utama
Haleon PLC - Tambahing bathi saben saham ing taun lumaku|KVUE (Kenvue Corp) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Verona Pharma Inc. VRNA|Wutah bathi saben saham ing taun lumaku Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Amneal AMRX|Perrigo Company PLC - Wutah bathi saben saham ing taun lumaku|Alvotech Corp - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Liquidia Inc.|GLPG (Galapagos NV) - Wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun iki ANIP|MNKD (MannKind) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Amphastar Pharmaceuticals Inc|Wutah bathi saben saham ing taun lumaku Pacira (PCRX)|SPRY (ARS Corp) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku TBPH (Theravance Biopharma)|Prakiraan wutah bathi resik saben saham ing taun iki aquestive.com (AQST)|scPharma - Wutah bathi ing taun lumaku|TECX - Wutah bathi ing taun lumaku|TNXP (Tonix Pharmaceuticals Inc.) - Wutah bathi resik saben saham ing taun iki|China SXT Pharmaceuticals, Inc. - Tambahing bathi saben saham ing taun lumaku|EPRX (Eupraxia Pharmaceuticals, Inc.) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku BHST|Wutah bathi ing taun lumaku EXOZ|Prakiraan wutah bathi resik saben saham ing taun iki oramed.com|Wutah bathi saben saham ing taun lumaku Entera Bio ENTX|MindWalk Therapeutics (HYFT) - Kacepetan wutah bathi saben saham ing taun lumaku|ABVC - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki cumberlandpharma.com CPIX|QNTM: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki FibroGen Inc|TELO (Telomir Pharma) - Wutah bathi ing taun lumaku|Rani Therapeutics Inc (RANI) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku SNYR|RLYB - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Pulmatrix PULM|PTHL: Wutah bathi saben saham ing taun iki|Aptorum - Wutah bathi ing taun lumaku|Lyra Therapeutics Inc (LYRA) - Wutah bathi resik saben saham ing taun iki|IBO: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku TNF Pharmaceuticals, Inc. (TNFA)|Wutah bathi saben saham ing taun lumaku cbdMD Inc.|Wutah bathi saben saham ing taun lumaku PRFX|Wutah bathi ing taun lumaku CYTO|LIPO - Kacepetan wutah bathi saben saham ing taun lumaku|OptiNose, Inc. - Wutah bathi resik saben saham ing taun iki|PIRS: Wutah bathi saben saham ing taun iki|PROC: Wutah bathi resik saben saham ing taun iki|PTPI (Petros Pharmaceuticals Inc) - Wutah bathi saben saham ing taun iki|Qilian International Holding Group Limited (QLI) - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku SLRN (ACELYRIN Inc.)|TFFP (TFF Pharmaceuticals) - Wutah bathi ing taun lumaku
